{"id":201603,"title":"Notice to Stakeholders: Release of the Product Monograph Template - Schedule D - Biosimilar Biologic Drug - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2025-04-19","captureTimestamp":"2025-04-19T14:02:20.592000+00:00","jobId":1,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/notice-stakeholders-release-product-monograph-template-schedule-d-biosimilar-biologic-drug.html?wbdisable=false","snippet":"Notice to Stakeholders: Release of the Product Monograph Template - Schedule D - Biosimilar Biologic Drug - Canada.ca Skip to main content Skip to \"About government\" We have archived this page and will not be updating it. You can use it for research or reference. Language…","rawSnapshotUrl":"/api/snapshots/raw/201603","browseUrl":"https://replay.healtharchive.ca/job-1/20250419140220/https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/notice-stakeholders-release-product-monograph-template-schedule-d-biosimilar-biologic-drug.html?wbdisable=false#ha_snapshot=201603","mimeType":"text/html","statusCode":200}